A powerful Senate Republican heralded on Wednesday a slate of policies aimed at lowering the price of prescription medicines — and outlined a clear path forward for passing them into law with bipartisan, bicameral support.

Sen. Chuck Grassley, the Iowa Republican who chairs the Senate Finance Committee, said his “good working relationship” with ranking member Sen. Ron Wyden (D-Ore.), along with his conversations with other key lawmakers in the House and on the Health, Education, Labor, and Pensions Committee, present a “real opportunity” for a collaborative product — brought by both committees to the Senate floor — by the end of this year.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy